Skip to main content
. 2020 Nov 4;12(11):3264. doi: 10.3390/cancers12113264

Table 1.

Dysregulated miRNAs in thyroid cancer.

miRNA Alteration Mechanism Thyroid Cancer Type Sample Ref.
miR-146a/b-5p ↓ RAR-β PTC Cell line and tissue [52]
miR-155 ↓ SOCS1 ATC [53]
miR-21 ↓ VHL → ↑ N-cadherin and vimentin PTC [54]
miR-574-5p ↓ SCAI → ↑ β-catenin [55]
miR-625-3p ↑ Bcl-2, ↓ Bax, and cleaved caspase 3/9 [56]
miR-96 ↓ FOXO1 → ↓ Bim Cell line [57]
Let-7a Not known Not known Tissue [58]
miR-125a-5p ↑ CD147 → ↓ glucose metabolism PTC, FTC, MTC and ATC Cell line and tissue [59]
miR-1266 ↑ FGFR2 PTC [60]
miR-141-3p ↑ YY1 [61]
miR-144 ↑ TGF-α ATC [62]
miR-148a ↑ INO80 ATC cancer stem cells [63]
miR-150 ↑ROCK1 PTC Cell line and tissue [64]
miR-195 ↑ CCND1 and FGF2 → ↑ β-catenin, c-Myc, cyclin D1 and MMP-13 [65]
miR-199b-5p ↑ STON2 → ↑ N-cadherin and fibronectin [66]
miR-375 ↑ ERBB2 [57]
miR-497 ↑ AKT3 [67]
miR-524-5p ↑ FOXE1 and ITGA3 [68]
miR-7 ↑ PAK1 [69]
miR-873-5p ↑ CXCL16 → ↑ p-p65 and p-Rel-B, MMP1, MMP9 and MMP13 [70]
miR-9-5p ↑ BRAF [67]

PTC: Papillary Thyroid Cancer; FTC: Follicular Thyroid Cancer; ATC: Anaplastic Thyroid Cancer; MTC: Medullar Thyroid Cancer; FOXN3: Forkhead Box N3; QKI5-7: Quaking protein 5-7; SCAI: Suppressor of Cancer Cell Invasion; CXCL16: C-X-C Motif Chemokine Ligand 16; SOCS1: Suppressor Protein of Cytokine Signaling 1; MMP1: Matrix Metallopeptidase 1; VHL: Von Hippel-Lindau Tumor Suppressor; RAR-β: Retinoic Acid Receptor Beta; FOXE1: Forkhead Box E1; ITGA3: Integrin Subunit Alpha 3; HK2: Hexokinase 2; YY1: Yin Yang 1; STON2: Stonin 2; FGFR2: Fibroblast Growth Factor Receptor 2; TGF-α: Transforming Growth Factor Alpha; AKT3: RAC-γ serine/threonine-protein kinase; CCND1: Cyclin D1; FGF2: Fibroblast Growth Factor; ROCK1: Rho-associated Protein Kinase 1; PAK1: p21 Activated Kinase-1; ERBB2: Erb-B2 Receptor Tyrosine Kinase 2; FOXO1: Forkhead Box O1.